News
Roivant Sciences secures $5.2B for advancing late-stage drugs like IMVT-1402 & brepocitinib. Click here to read an analysis ...
We recently published a list of 10 Best Low Priced Growth Stocks To Invest In. In this article, we are going to take a look at where ​​Roivant Sciences Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback